Maven Securities LTD Has $514,000 Position in Aspen Aerogels, Inc. $ASPN

Key Points

• Maven Securities LTD increased its stake in Aspen Aerogels, Inc. by 168.1%, owning 80,421 shares valued at $514,000 as of the latest SEC filing.
• Aspen Aerogels reported a quarterly earnings beat with an EPS of ($0.04), exceeding the expected loss of ($0.12), while its revenue decreased by 33.8% year-over-year.
• Recent analyst activity includes Barclays downgrading the stock from "equal weight" to "underweight" and raising the price target from $7.00 to $16.00.

Maven Securities LTD grew its stake in Aspen Aerogels, Inc. (NYSE:ASPN - Free Report) by 168.1% during the first quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 80,421 shares of the construction company's stock after purchasing an additional 50,421 shares during the quarter. Maven Securities LTD owned approximately 0.10% of Aspen Aerogels worth $514,000 as of its most recent filing with the SEC.

Other institutional investors have also modified their holdings of the company. GAMMA Investing LLC raised its stake in shares of Aspen Aerogels by 1,998.7% in the 1st quarter. GAMMA Investing LLC now owns 3,316 shares of the construction company's stock valued at $210,000 after purchasing an additional 3,158 shares in the last quarter. Banque Cantonale Vaudoise acquired a new position in Aspen Aerogels in the first quarter valued at approximately $45,000. Exchange Traded Concepts LLC boosted its stake in Aspen Aerogels by 460.4% in the first quarter. Exchange Traded Concepts LLC now owns 7,436 shares of the construction company's stock valued at $48,000 after acquiring an additional 6,109 shares during the period. Sandia Investment Management LP acquired a new position in Aspen Aerogels in the fourth quarter valued at approximately $89,000. Finally, CWM LLC boosted its stake in Aspen Aerogels by 2,137.9% in the first quarter. CWM LLC now owns 8,325 shares of the construction company's stock valued at $53,000 after acquiring an additional 7,953 shares during the period. Institutional investors and hedge funds own 97.64% of the company's stock.

Aspen Aerogels Price Performance

NYSE:ASPN traded down $0.0350 during midday trading on Monday, hitting $6.9750. 253,764 shares of the stock were exchanged, compared to its average volume of 2,027,478. Aspen Aerogels, Inc. has a one year low of $4.16 and a one year high of $32.31. The company has a market capitalization of $574.46 million, a price-to-earnings ratio of -1.83 and a beta of 2.73. The business has a 50-day moving average price of $6.91 and a two-hundred day moving average price of $6.72. The company has a current ratio of 3.98, a quick ratio of 3.31 and a debt-to-equity ratio of 0.34.

Aspen Aerogels (NYSE:ASPN - Get Free Report) last announced its earnings results on Thursday, August 7th. The construction company reported ($0.04) EPS for the quarter, topping the consensus estimate of ($0.12) by $0.08. Aspen Aerogels had a positive return on equity of 2.92% and a negative net margin of 78.53%.The firm had revenue of $78.02 million for the quarter, compared to analysts' expectations of $72.53 million. During the same quarter in the previous year, the company earned $0.21 earnings per share. The firm's quarterly revenue was down 33.8% compared to the same quarter last year. Aspen Aerogels has set its FY 2025 guidance at -3.860--3.730 EPS. Sell-side analysts predict that Aspen Aerogels, Inc. will post 0.17 EPS for the current year.

Insider Transactions at Aspen Aerogels

In other Aspen Aerogels news, CAO Santhosh P. Daniel sold 4,410 shares of the business's stock in a transaction on Tuesday, August 12th. The shares were sold at an average price of $7.31, for a total transaction of $32,237.10. Following the sale, the chief accounting officer directly owned 19,879 shares of the company's stock, valued at $145,315.49. The trade was a 18.16% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. 4.30% of the stock is currently owned by company insiders.

Analysts Set New Price Targets

A number of equities analysts have commented on the company. Oppenheimer downgraded Aspen Aerogels from an "outperform" rating to a "market perform" rating in a research note on Thursday, May 8th. Barclays cut shares of Aspen Aerogels from an "equal weight" rating to an "underweight" rating and upped their target price for the stock from $7.00 to $16.00 in a research report on Monday, August 11th. Finally, Canaccord Genuity Group decreased their target price on shares of Aspen Aerogels from $11.00 to $10.00 and set a "buy" rating for the company in a research report on Friday, August 8th. One equities research analyst has rated the stock with a Strong Buy rating, six have assigned a Buy rating, two have issued a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy" and a consensus target price of $19.50.

About Aspen Aerogels

Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.